USD 0.04
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 472.42 Thousand USD | 26410.83% |
2022 | 1782.00 USD | -2.68% |
2021 | 1831.00 USD | -95.4% |
2020 | 39.8 Thousand USD | -93.49% |
2019 | 611.69 Thousand USD | 0.12% |
2018 | 610.96 Thousand USD | -45.81% |
2017 | 1.12 Million USD | 0.0% |
2015 | 1.12 Million USD | -0.17% |
2014 | 1.12 Million USD | 100649.26% |
2013 | 1115.37 USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 250.63 Thousand USD | 624.53% |
2024 Q1 | 34.59 Thousand USD | -92.68% |
2023 Q4 | 472.42 Thousand USD | 7.07% |
2023 Q3 | 441.24 Thousand USD | -38.79% |
2023 Q2 | 720.81 Thousand USD | -6.4% |
2023 Q1 | 770.06 Thousand USD | 43113.64% |
2023 FY | 472.42 Thousand USD | 26410.83% |
2022 Q3 | 3573.46 USD | 295.29% |
2022 FY | 1782.00 USD | -2.68% |
2022 Q4 | 1782.00 USD | -50.13% |
2022 Q2 | 904.00 USD | -75.69% |
2022 Q1 | 3718.00 USD | 0.0% |
2021 FY | 1831.00 USD | -95.4% |
2021 Q3 | 3319.00 USD | -64.11% |
2021 Q2 | 9247.00 USD | 0.0% |
2020 Q2 | 610.98 Thousand USD | 0.0% |
2020 Q1 | 610.95 Thousand USD | 0.0% |
2020 Q3 | 646.72 Thousand USD | 5.85% |
2020 FY | 39.8 Thousand USD | -93.49% |
2019 FY | 611.69 Thousand USD | 0.12% |
2018 Q1 | 1.12 Million USD | 0.0% |
2018 FY | 610.96 Thousand USD | -45.81% |
2017 FY | 1.12 Million USD | 0.0% |
2015 FY | 1.12 Million USD | -0.17% |
2014 FY | 1.12 Million USD | 100649.26% |
2013 FY | 1115.37 USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
American Bio Medica Corporation | 1.26 Million USD | 62.772% |
Arrayit Corporation | 1 Million USD | 52.776% |
Atlantic International Corp. | 4.43 Million USD | 89.351% |
Biocept, Inc. | 30.87 Million USD | 98.47% |
Bioqual, Inc. | 56.58 Million USD | 99.165% |
CardioGenics Holdings Inc | 231.93 Thousand USD | -103.69% |
DermTech, Inc. | 121.93 Million USD | 99.613% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.989% |
HTG Molecular Diagnostics, Inc. | 17.77 Million USD | 97.343% |
iMD Companies, Inc. | 190.13 Thousand USD | -148.465% |
IDenta Corp. | 1.52 Million USD | 69.108% |
Interpace Biosciences, Inc. | 13.02 Million USD | 96.372% |
Integrative Health Technologies, Inc. | 8.25 Million USD | 94.275% |
InVitro International | 1.53 Million USD | 69.203% |
Lumos Diagnostics Holdings Limited | 26.83 Million USD | 98.24% |
Many Bright Ideas Technologies Inc. | 2312.00 USD | -20333.521% |
Medical Imaging Corp. | 4.19 Million USD | 88.729% |
NovelStem International Corp. | 2.25 Million USD | 79.046% |
Optigenex Inc. | 1.88 Million USD | 74.981% |
PharmChem, Inc. | 2.76 Million USD | 82.918% |
Proteome Sciences plc | 14.58 Million USD | 96.761% |
Response Genetics, Inc | 48.88 Million USD | 99.034% |
Rennova Health, Inc. | 20.57 Million USD | 97.704% |
RushNet, Inc. | 6.04 Million USD | 92.188% |
ScreenPro Security Inc. | 1.26 Million USD | 62.547% |
StageZero Life Sciences Ltd. | 700.65 Thousand USD | 32.574% |
Todos Medical Ltd. | 15.26 Million USD | 96.906% |